FDA approves Roche’s Actemra for the treatment of COVID-19 in hospitalised adults December 21, 2022January 20, 2023 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: Roche’s Actemra/RoActemra receives U.S. FDA…U.S. FDA grants priority review to Roche’s…Phase II/III trial shows Ronapreve™ (casirivimab and…European Commission approves Roche’s Gavreto…CHMP recommends EU approval of Ronapreve to treat…Ronapreve approved by European Commission to treat…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
